Page 19 - AN-4-3

Advanced Neurology Stem cell therapy in stroke treatment: Advances and prospects

and rescues memory deficits in Alzheimer’s disease markers. PLoS One. 2015;10(4):e0122465.
mice by modulation of immune responses. Stem Cells. doi: 10.1371/journal.pone.0122465
2010;28(2):329-343.
53. Maric DM, Velikic G, Maric DL, et al. Stem cell homing in
doi: 10.1002/stem.277
intrathecal applications and inspirations for improvement
43. Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, paths. Int J Mol Sci. 2022;23(8):4290.
Fibbe WE. Mesenchymal stem cells inhibit generation and doi: 10.3390/ijms23084290
function of both CD34+-derived and monocyte-derived
dendritic cells. J Immunol. 2006;177(4):2080-2087. 54. Zhao X, Li Q, Guo Z, Li Z. Constructing a cell
microenvironment with biomaterial scaffolds for stem cell
doi: 10.4049/jimmunol.177.4.2080
therapy. Stem Cell Res Ther. 2021;12:1-3.
44. Melief SM, Geutskens SB, Fibbe WE, Roelofs H. Multipotent doi: 10.1186/s13287-021-02650-w
stromal cells skew monocytes towards an anti-inflammatory
interleukin-10-producing phenotype by production of 55. Kim SJ, Moon GJ, Cho YH, et al. Circulating mesenchymal
interleukin-6. Haematologica. 2013;98(6):888. stem cells microparticles in patients with cerebrovascular
disease. PLoS One. 2012;7(5):e37036.
doi: 10.3324/haematol.2012.078055
doi: 10.1371/journal.pone.0037036
45. Dayan V, Yannarelli G, Billia F, et al. Mesenchymal stromal
cells mediate a switch to alternatively activated monocytes/ 56. Lai RC, Tan SS, Teh BJ, et al. Proteolytic potential of the MSC
macrophages after acute myocardial infarction. Basic Res exosome proteome: Implications for an exosome‐mediated
Cardiol. 2011;106:1299-1310. delivery of therapeutic proteasome. Int J Proteomics.
2012;2012:971907.
doi: 10.1007/s00395-011-0221-9
doi: 10.1155/2012/971907
46. Németh K, Leelahavanichkul A, Yuen PS, et al. Bone
marrow stromal cells attenuate sepsis via prostaglandin E2– 57. Meneghini V, Frati G, Sala D, et al. Generation of human
dependent reprogramming of host macrophages to increase induced pluripotent stem cell-derived bona fide neural
their interleukin-10 production. Nat Med. 2009;15(1):42-49. stem cells for ex vivo gene therapy of metachromatic
leukodystrophy. Stem Cells Transl Med. 2017;6(2):352-368.
doi: 10.1038/nm.1905
doi: 10.5966/sctm.2015-0414
47. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in
health and disease. Nat Rev Immunol. 2008;8(9):726-736. 58. Kropp C, Massai D, Zweigerdt R. Progress and challenges
in large-scale expansion of human pluripotent stem cells.
doi: 10.1038/nri2395
Process Biochem. 2017;59:244-254.
48. Bernardo ME, Fibbe WE. Mesenchymal stromal cells: doi: 10.1016/j.procbio.2016.09.032
Sensors and switchers of inflammation. Cell Stem Cell.
2013;13(4):392-402. 59. Jin Y, Li S, Yu Q, Chen T, Liu D. Application of stem cells in
regeneration medicine. MedComm (2020). 2023;4(4):e291.
doi: 10.1016/j.stem.2013.09.006
doi: 10.1002/mco2.291
49. Kimbrel EA, Lanza R. Next-generation stem cells-ushering
in a new era of cell-based therapies. Nat Rev Drug Discov. 60. Ma ZJ, Yang JJ, Lu YB, Liu ZY, Wang XX. Mesenchymal
2020;19(7):463-479. stem cell-derived exosomes: Toward cell-free therapeutic
strategies in regenerative medicine. World J Stem Cells.
doi: 10.1038/s41573-020-0064-x
2020;12(8):814.
50. Li J, Zhang Q, Wang W, Lin F, Wang S, Zhao J. Mesenchymal doi: 10.4252/wjsc.v12.i8.814
stem cell therapy for ischemic stroke: A look into
treatment mechanism and therapeutic potential. J Neurol. 61. van Griensven M, Balmayor ER. Extracellular vesicles are
2021;268:4095-4107. key players in mesenchymal stem cells’ dual potential to
regenerate and modulate the immune system. Adv Drug
doi: 10.1007/s00415-020-10138-5
Deliv Rev. 2024;2014:115203.
51. Hao L, Zou Z, Tian H, Zhang Y, Zhou H, Liu L. Stem
cell‐based therapies for ischemic stroke. Biomed Res Int. doi: 10.1016/j.addr.2024.115203
2014;2014:468748. 62. Tang P, Song F, Chen Y, et al. Preparation and characterization
of extracellular vesicles and their cutting-edge applications
doi: 10.1155/2014/468748
in regenerative medicine. Appl Mater Today. 2024;37:102084.
52. Ali H, Al-Yatama MK, Abu-Farha M, Behbehani K, Al
Madhoun A. Multi-lineage differentiation of human doi: 10.1016/j.apmt.2024.102084
umbilical cord Wharton’s jelly mesenchymal stromal cells 63. Ramasubramanian L, Kumar P, Wang A. Engineering
mediates changes in the expression profile of stemness extracellular vesicles as nanotherapeutics for regenerative

Volume 4 Issue 3 (2025) 13 doi: 10.36922/an.5582